Organon & Co. (OGN)
13.85
+0.03
(+0.22%)
USD |
NYSE |
Nov 03, 13:31
Organon Cash and Short Term Investments (Quarterly) : 1.455B for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.455B |
| June 30, 2026 | 1.132B |
| March 31, 2026 | 1.116B |
| December 31, 2025 | 574.00M |
| September 30, 2025 | 672.00M |
| June 30, 2025 | 599.00M |
| March 31, 2025 | 547.00M |
| December 31, 2024 | 675.00M |
| September 30, 2024 | 763.00M |
| June 30, 2024 | 704.00M |
| March 31, 2024 | 575.00M |
| December 31, 2023 | 693.00M |
| Date | Value |
|---|---|
| September 30, 2023 | 414.00M |
| June 30, 2023 | 326.00M |
| March 31, 2023 | 459.00M |
| December 31, 2022 | 706.00M |
| September 30, 2022 | 499.00M |
| June 30, 2022 | 545.00M |
| March 31, 2022 | 694.00M |
| December 31, 2021 | 737.00M |
| September 30, 2021 | 1.008B |
| June 30, 2021 | 730.00M |
| March 31, 2021 | 141.00M |
| December 31, 2020 | 12.00M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Viatris, Inc. | 1.410B |
| Pacira Biosciences, Inc. | 251.03M |
| Bristol Myers Squibb Co. | 12.58B |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |